PROGYNY INC (PGNY) Stock Fundamental Analysis
NASDAQ:PGNY - Nasdaq - US74340E1038 - Common Stock - Currency: USD
Taking everything into account, PGNY scores 6 out of 10 in our fundamental rating. PGNY was compared to 103 industry peers in the Health Care Providers & Services industry. PGNY gets an excellent profitability rating and is at the same time showing great financial health properties. PGNY has a decent growth rate and is not valued too expensively. With these ratings, PGNY could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year PGNY was profitable.
PGNY had a positive operating cash flow in the past year.
In the past 5 years PGNY has always been profitable.
Each year in the past 5 years PGNY had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.19%, PGNY belongs to the top of the industry, outperforming 89.32% of the companies in the same industry.
PGNY has a Return On Equity of 11.24%. This is in the better half of the industry: PGNY outperforms 76.70% of its industry peers.
PGNY's Return On Invested Capital of 11.34% is amongst the best of the industry. PGNY outperforms 87.38% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PGNY is in line with the industry average of 9.55%.
The 3 year average ROIC (8.25%) for PGNY is below the current ROIC(11.34%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.19% | ||
| ROE | 11.24% | ||
| ROIC | 11.34% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
1.3 Margins
PGNY's Profit Margin of 4.33% is fine compared to the rest of the industry. PGNY outperforms 74.76% of its industry peers.
In the last couple of years the Profit Margin of PGNY has declined.
The Operating Margin of PGNY (6.03%) is better than 63.11% of its industry peers.
PGNY's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 21.99%, PGNY perfoms like the industry average, outperforming 47.57% of the companies in the same industry.
In the last couple of years the Gross Margin of PGNY has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.03% | ||
| PM (TTM) | 4.33% | ||
| GM | 21.99% |
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
2. Health
2.1 Basic Checks
PGNY has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for PGNY has been reduced compared to 1 year ago.
PGNY has more shares outstanding than it did 5 years ago.
PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
PGNY has an Altman-Z score of 7.24. This indicates that PGNY is financially healthy and has little risk of bankruptcy at the moment.
PGNY has a better Altman-Z score (7.24) than 90.29% of its industry peers.
There is no outstanding debt for PGNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 7.24 |
ROIC/WACC1.28
WACC8.87%
2.3 Liquidity
A Current Ratio of 2.39 indicates that PGNY has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.39, PGNY belongs to the top of the industry, outperforming 82.52% of the companies in the same industry.
PGNY has a Quick Ratio of 2.39. This indicates that PGNY is financially healthy and has no problem in meeting its short term obligations.
PGNY has a better Quick ratio (2.39) than 83.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.39 | ||
| Quick Ratio | 2.39 |
3. Growth
3.1 Past
The earnings per share for PGNY have decreased by -6.56% in the last year.
Measured over the past years, PGNY shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.77% on average per year.
Looking at the last year, PGNY shows a quite strong growth in Revenue. The Revenue has grown by 9.46% in the last year.
The Revenue has been growing by 38.42% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-6.56%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)9.46%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%16.53%
3.2 Future
PGNY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.89% yearly.
PGNY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.02% yearly.
EPS Next Y-2.07%
EPS Next 2Y29%
EPS Next 3Y25.02%
EPS Next 5Y31.89%
Revenue Next Year7.35%
Revenue Next 2Y9.35%
Revenue Next 3Y10.56%
Revenue Next 5Y9.02%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 40.67 indicates a quite expensive valuation of PGNY.
Compared to the rest of the industry, the Price/Earnings ratio of PGNY is on the same level as its industry peers.
PGNY's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.24.
Based on the Price/Forward Earnings ratio of 24.44, the valuation of PGNY can be described as rather expensive.
PGNY's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of PGNY to the average of the S&P500 Index (36.42), we can say PGNY is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.67 | ||
| Fwd PE | 24.44 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PGNY is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, PGNY is valued cheaper than 84.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.15 | ||
| EV/EBITDA | 19.89 |
4.3 Compensation for Growth
PGNY has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as PGNY's earnings are expected to grow with 25.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29%
EPS Next 3Y25.02%
5. Dividend
5.1 Amount
PGNY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
23.18
+0.69 (+3.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.2%
Inst Owner Change-0.64%
Ins Owners1.37%
Ins Owner Change1.55%
Market Cap1.99B
Analysts77.5
Price Target27.25 (17.56%)
Short Float %9.95%
Short Ratio7.44
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.62%
Min EPS beat(2)-11.77%
Max EPS beat(2)15%
EPS beat(4)1
Avg EPS beat(4)-4.37%
Min EPS beat(4)-19.12%
Max EPS beat(4)15%
EPS beat(8)5
Avg EPS beat(8)12.82%
EPS beat(12)9
Avg EPS beat(12)54.88%
EPS beat(16)13
Avg EPS beat(16)111.04%
Revenue beat(2)2
Avg Revenue beat(2)4.47%
Min Revenue beat(2)3.19%
Max Revenue beat(2)5.74%
Revenue beat(4)2
Avg Revenue beat(4)0.3%
Min Revenue beat(4)-5.35%
Max Revenue beat(4)5.74%
Revenue beat(8)4
Avg Revenue beat(8)-0.24%
Revenue beat(12)7
Avg Revenue beat(12)0.33%
Revenue beat(16)7
Avg Revenue beat(16)-0.81%
PT rev (1m)0%
PT rev (3m)-2.09%
EPS NQ rev (1m)2.36%
EPS NQ rev (3m)-10.71%
EPS NY rev (1m)1.39%
EPS NY rev (3m)-6.86%
Revenue NQ rev (1m)1.47%
Revenue NQ rev (3m)3.88%
Revenue NY rev (1m)0.56%
Revenue NY rev (3m)1.78%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.67 | ||
| Fwd PE | 24.44 | ||
| P/S | 1.64 | ||
| P/FCF | 10.15 | ||
| P/OCF | 9.78 | ||
| P/B | 4.25 | ||
| P/tB | 4.51 | ||
| EV/EBITDA | 19.89 |
EPS(TTM)0.57
EY2.46%
EPS(NY)0.95
Fwd EY4.09%
FCF(TTM)2.28
FCFY9.85%
OCF(TTM)2.37
OCFY10.23%
SpS14.15
BVpS5.45
TBVpS5.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.19% | ||
| ROE | 11.24% | ||
| ROCE | 14.82% | ||
| ROIC | 11.34% | ||
| ROICexc | 23.6% | ||
| ROICexgc | 26.56% | ||
| OM | 6.03% | ||
| PM (TTM) | 4.33% | ||
| GM | 21.99% | ||
| FCFM | 16.14% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
ROICexc(3y)19.18%
ROICexc(5y)17.15%
ROICexgc(3y)20.6%
ROICexgc(5y)18.86%
ROCE(3y)10.79%
ROCE(5y)10.01%
ROICexcg growth 3Y11.16%
ROICexcg growth 5Y-10.91%
ROICexc growth 3Y11.54%
ROICexc growth 5Y-2.19%
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
F-Score7
Asset Turnover1.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 207.4% | ||
| Cap/Sales | 0.61% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 265.01% | ||
| Profit Quality | 372.94% | ||
| Current Ratio | 2.39 | ||
| Quick Ratio | 2.39 | ||
| Altman-Z | 7.24 |
F-Score7
WACC8.87%
ROIC/WACC1.28
Cap/Depr(3y)177.5%
Cap/Depr(5y)150.16%
Cap/Sales(3y)0.4%
Cap/Sales(5y)0.39%
Profit Quality(3y)290.66%
Profit Quality(5y)196.79%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.56%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-2.07%
EPS Next 2Y29%
EPS Next 3Y25.02%
EPS Next 5Y31.89%
Revenue 1Y (TTM)9.46%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%16.53%
Revenue Next Year7.35%
Revenue Next 2Y9.35%
Revenue Next 3Y10.56%
Revenue Next 5Y9.02%
EBIT growth 1Y11.23%
EBIT growth 3Y27.82%
EBIT growth 5Y41.01%
EBIT Next Year26.8%
EBIT Next 3Y17.86%
EBIT Next 5Y15.2%
FCF growth 1Y79.62%
FCF growth 3Y93.67%
FCF growth 5YN/A
OCF growth 1Y80.28%
OCF growth 3Y90.18%
OCF growth 5YN/A